Onco-BCG 40 mg (BCG for Immunotherapy I.P.) In Pakistan

Onco-BCG 40mg is a prescription immunotherapy medicine containing live, attenuated Mycobacterium bovis Bacillus Calmette-Guérin (BCG). It is used by specialist urologists for the treatment of certain types of non-muscle-invasive bladder cancer.

Onco-BCG works by stimulating a local immune response inside the urinary bladder, helping the body's immune system recognise and attack abnormal cancer cells. It is supplied as a freeze-dried preparation that must be reconstituted before use.

This medicine is intended for intravesical instillation only, meaning it is administered directly into the bladder through a urinary catheter by trained healthcare professionals.

Product Information

CDSCO+2

Uses and Indications

Onco-BCG 40mg may be prescribed for:

• Carcinoma in situ (CIS) of the urinary bladder.

• Certain superficial non-muscle-invasive bladder cancers.

• Treatment following transurethral resection of bladder tumour (TURBT).

• Reducing the risk of recurrence of certain bladder tumours.

• Helping prevent progression of selected non-muscle-invasive bladder cancers.

Treatment suitability depends on the tumour stage, clinical condition and specialist assessment.

How Does Onco-BCG Work?

Onco-BCG stimulates the immune system inside the bladder. After intravesical administration, the BCG organisms trigger a local inflammatory and immune response involving immune cells such as macrophages and lymphocytes.

This immune response helps the body target abnormal bladder cells and can reduce the risk of tumour recurrence in appropriately selected patients.

Dosage and Administration

• Onco-BCG must be administered by a qualified healthcare professional.

• It is introduced directly into the bladder through a urinary catheter.

• The medicine must be reconstituted using the specified sterile saline solution according to its official product instructions.

• Treatment schedules are determined by the treating urologist.

• The patient must follow the hospital's instructions before and after each treatment.

Important: Onco-BCG is not for intravenous, intramuscular or subcutaneous injection. It must not be used as a tuberculosis vaccine.

Possible Side Effects

Some patients may experience:

• Frequent urination.

• Burning or discomfort during urination.

• Blood in the urine.

• Mild fever or chills.

• Bladder irritation.

• Fatigue or general discomfort.

• Flu-like symptoms.

Persistent fever, severe urinary symptoms, worsening blood in the urine or signs of systemic infection require urgent medical assessment. Because Onco-BCG contains live attenuated bacteria, serious BCG infection is also a recognised risk.

Warnings and Precautions

Before treatment, patients should inform their urologist about existing medical conditions and medicines.

Important precautions include:

• Active infection: Treatment should be postponed in patients with an active urinary tract infection.

• Immune suppression: It is generally contraindicated in patients with significantly impaired immune function.

• Active tuberculosis: Patients with active tuberculosis should not receive this treatment.

• Urinary tract injury: Treatment should be delayed following traumatic catheterisation or bladder injury.

• Fever: Unexplained fever requires medical evaluation before treatment.

• Pregnancy and breastfeeding: Safety has not been established; specialist assessment is essential.

Healthcare professionals must follow appropriate infection-control procedures because the product contains live BCG organisms.

Storage Instructions

• Store refrigerated at 2°C to 8°C.

• Protect the vial from direct light.

• Do not freeze.

• Keep in its original packaging until use.

• Follow the manufacturer's instructions for reconstitution.

• Use the reconstituted preparation within the specified time and discard any unused portion as directed.

• Handle and dispose of used materials according to biohazard safety procedures.

The official product information specifies that reconstituted material should be protected from light and, if not used immediately, kept refrigerated for no longer than four hours.

Onco-BCG 40mg Price in Pakistan

The price of Onco-BCG 40mg in Pakistan may vary depending on supplier, import status and availability.

For the latest price, stock confirmation and ordering information, contact Onlinetrade.pk.

Buy Onco-BCG 40mg in Pakistan

Looking for Onco-BCG 40mg (BCG for Immunotherapy I.P.) in Pakistan? Contact Onlinetrade.pk for product details, current pricing and availability.

Before purchasing, confirm the product's authenticity, manufacturer, batch number, expiry date and cold-chain storage history. This medicine should only be used under the supervision of a qualified urologist.

Available Across Pakistan

Customers can contact Onlinetrade.pk for availability and delivery information in:

Lahore, Karachi, Islamabad, Bahawalpur, Peshawar, Multan, Gujranwala, Rawalpindi, Hyderabad, Faisalabad, Larkana, Sukkur, Sialkot and all other major cities of Pakistan.

Availability and delivery arrangements must be confirmed before ordering.

Frequently Asked Questions (FAQs)

1. What is Onco-BCG 40mg used for?

It is used as immunotherapy for certain types of non-muscle-invasive bladder cancer, including carcinoma in situ.

2. What is the active ingredient in Onco-BCG?

It contains live attenuated Bacillus Calmette-Guérin (BCG), derived from Mycobacterium bovis.

3. How is Onco-BCG administered?

It is administered directly into the urinary bladder through a catheter by trained healthcare professionals.

4. Is Onco-BCG a tuberculosis vaccine?

No. Onco-BCG is specifically formulated for bladder cancer immunotherapy and must not be used as a tuberculosis vaccine.

5. Does Onco-BCG require refrigeration?

Yes. It should be stored between 2°C and 8°C and protected from light.

6. Can Onco-BCG be injected into a vein or muscle?

No. It is strictly for intravesical administration and must never be administered intravenously, intramuscularly or subcutaneously.